The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: analysis of the NHANES 2017–2018 cycle - Alkhouri, Naim; Almomani, Ashraf; Le, Phuc; Payne, Julia Y.; Asaad, Imad; Polanco, Prido; Leff, Phillip; Kumar, Prabhat; Noureddin, Mazen (BMC gastroenterology, 2024)
Keywords: Adult; Advanced fibrosis; AGILE; Biopsy; Body mass index; Care and treatment; Cirrhosis; Diagnosis; Disease control; Distribution; Elastography; Fatty Liver - complications; Fatty Liver - epidemiology; Female; Fibrosis; Gastroenterology; Gender; Hemoglobin; Hepatitis B; Hepatology; Humans; Internal Medicine; Liver cirrhosis; Liver Cirrhosis - epidemiology; Liver diseases; Male; MASLD; Medicine; Medicine & Public Health; Metabolic diseases; Metabolism; Middle Aged; NHANES; Nutrition Surveys; Obesity; Population; Predictive Value of Tests; Prevalence; Severity of Illness Index; United States - epidemiology; United States; United States--US; Cirrhosis; AGILE; NHANES; Advanced fibrosis; MASLD; Elastography